Incorporating direct-to-consumer genomic information into patient care: Attitudes and experiences of primary care physicians

Personalized Medicine

Volumn 9, Issue 7, 2012, Pages 683-692

  Bernhardt, Barbara A ^a,b   Zayac, Cara ^b   Gordon, Erynn S ^c   Wawak, Lisa ^c   Pyeritz, Reed E ^a,b   Gollust, Sarah E ^d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

genetic testing; genetics; genomics; pharmacogenomics; physician experience; physician readiness

Indexed keywords

WARFARIN;

ADULT; CONSUMER HEALTH INFORMATION; DIRECT TO CONSUMER HEALTH INFORMATION; FEMALE; GENETIC RISK; GENETIC SCREENING; GENOMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHARMACOGENOMICS; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; WORK EXPERIENCE;

EID: 84866358640     PISSN: 17410541     EISSN: 1744828X     Source Type: Journal    
DOI: 10.2217/pme.12.80     Document Type: Review

References (45)

1. Greendale K, Pyeritz RE. Empowering primary care health professionals in medical genetics: how soon? How fast? How far? Am. J. Med. Genet. Semin. Med. Genet. 106(3), 223-232 (2001).
2. Scheuner MT, Sieverding P, Shekelle PG. Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 299(11), 1320-1334 (2008).
3. Suther SG, Goodson P. Texas physicians' perceptions of genomic medicine as an innovation. Clin. Genet. 65(5), 368-377 (2004).
4. Billings PR, Carlson RJ, Carlson J et al. Ready for genomic medicine? Perspectives of health care decision makers. Arch. Intern. Med. 165(16), 1917-1919 (2005).
5. Klitzman R, Chung W, Marder K et al. Attitudes and practices among internists concerning genetic testing. J. Genet. Couns. doi:10.1007/s10897-012- 9504-z (2012) (Epub ahead of print).
6. Nippert I, Harris HJ, Julian-Reynier C et al. Confidence of primary care physicians in their ability to carry out basic medical genetic tasks-a European survey in five countries-part 1. J. Community Genet. 2(1), 1-11 (2011).
7. Friedman LC, Cooper HP, Webb JA, Weinberg AD, Plon SE. Primary care physicians' attitudes and practices regarding cancer genetics: a comparison of 2001 with 1996 survey results. J. Cancer Educ. 18(2), 91-94 (2003).
8. Hamburg MA, Collins FS. The path to personalized medicine. N. Engl. J. Med. 363(4), 301-304 (2010).
9. Foster MW, Sharp RR. The contractual genome: how direct-to-consumer genomic services may help patients take ownership of their DNA. Per. Med. 5(4), 399-404 (2008).
10. Kolor K, Liu T, St Pierre J, Khoury MJ. Health care provider and consumer awareness, perceptions, and use of direct-to-consumer personal genomic tests, United States, 2008. Genet. Med. 11(8), 595 (2009).
11. Powell KP, Cogswell WA, Christianson CA et al. Primary care physicians' awareness, experience and opinions of direct-to-consumer genetic testing. J. Genet. Couns. 21(1), 113-126 (2012).
12. McGuire AL, Diaz CM, Wang T, Hilsenbeck SG. Social networkers' attitudes toward direct-to-consumer personal genome testing. Am. J. Bioeth. 9(6-7), 3-10 (2009).
13. Leighton JW, Valverde K, Bernhardt BA. The general public's understanding and perception of direct-to-consumer genetic test results. Public Health Genomics 15(1), 11-21 (2012).
14. Gollust SE, Gordon ES, Zayac C et al. Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics 15(1), 22-30 (2012).
15. Gordon ES, Griffin G, Wawak L, Pang H, Gollust SE, Bernhardt BA. 'It's not like judgment day': public understanding of and reactions to personalized genomic risk information. J. Genet. Couns. 21(3), 423-432 (2012).
16. Kaufman D, Bollinger JM, Dvoskin R, Scott J. Risky business: risk perception and the use of medical services among customers of DTC personal genetic testing. J. Genet. Couns. 21(3), 413-422 (2012).
17. Hunter DJ, Khoury MJ, Drazen JM. Letting the genome out of the bottle-will we get our wish? N. Engl. J. Med. 358(2), 105-107 (2008).
18. Arar N, Seo J, Abboud HE, Parchman M, Noel P. Providers' behavioral beliefs regarding the delivery of genomic medicine at the Veterans Health Administration. Per. Med. 7(5), 485-494 (2010).
19. Marteau TM, French DP, Griffin SJ et al. Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst. Rev. 10, CD007275 (2010).
20. Damani SB, Topol EJ. Emerging clinical applications in cardiovascular pharmacogenomics. Wiley Interdiscip. Rev. Syst. Biol. Med. 3(2), 206-215 (2011).
21. Hudson KL. Genomics, health care, and society. N. Engl. J. Med. 365(11), 1033-1041 (2011).
22. Manolopoulos VG, Dechairo B, Huriez A et al. Pharmacogenomics and personalized medicine in clinical practice. Pharmacogenomics 12(5), 597-610 (2011).
23. Tambor ES, Bernhardt BA, Rodgers J, Holtzman NA, Geller G. Mapping the human genome: an assessment of media coverage and public reaction. Genet. Med. 4(1), 31-36 (2002).
24. Etchegary H, Miller F, deLaat S, Wilson B, Carroll J, Cappelli M. Decision-making about inherited cancer risk: exploring dimensions of genetic responsibility. J. Genet. Couns. 18(3), 252-264 (2009).
25. Hahn S, Letvak S, Powell K et al. A community's awareness and perceptions of genomic medicine. Public Health Genomics 13(2), 63-71 (2010).
26. Shields AE, Burke W, Levy DE. Differential use of available genetic tests among primary care physicians in the United States: results of a national survey. Genet. Med. 10(6), 404-414 (2008).
27. Haga SB, Carrig MM, O'Daniel JM et al. Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling. J. Gen. Intern. Med. 26(8), 834-840 (2011).
28. Myers MF, Chang MH, Jorgensen C et al. Genetic testing for susceptibility to breast and ovarian cancer: evaluating the impact of a direct-to-consumer marketing campaign on physicians' knowledge and practices. Genet. Med. 8(6), 361-370 (2006).
29. Mouchawar J, Hensley-Alford S, Laurion S et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet. Med. 7(3), 191-197 (2005).
30. Stanek EJ, Sanders CL, Taber KA et al. Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey. Clin. Pharm. Ther. 91(3), 450-458 (2012).
31. Kadafour M, Haugh R, Posin M, Kayser SR, Shin J. Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics 10(11), 1853-1860 (2009).
32. Ormond KE, Hudgins L, Ladd JM, Magnus DM, Greely HT, Cho MK. Medical and graduate students' attitudes toward personal genomics. Genet. Med. 13(5), 400-408 (2011).
33. McGuire AL, Burke W. An unwelcome side effect of direct-to-consumer personal genome testing: raiding the medical commons. JAMA 300(22), 2669-2671 (2008).
34. Burke W, Evans JP. Teaching with single nucleotide polymorphisms: learning the right lessons. Genet. Med. 13(1), 17-18 (2011).
35. Feero WG, Green ED. Genomics education for health care professionals in the 21st century. JAMA 306(9), 989-990 (2011).
36. McInerney JD. Education in a genomic world. J. Med. Philos. 27(3), 369-390 (2002).
37. Powell KP, Christianson CA, Cogswell WA et al. Educational needs of primary care physicians regarding direct-to-consumer genetic testing. J. Genet. Couns. 21, 469-478 (2012).
38. Laedtke AL, O'Neill SM, Rubinstein WS, Vogel KJ. Family physicians' awareness and knowledge of the Genetic Information Non-discrimination Act (GINA). J. Genet. Couns. 21(2), 345-352 (2012).
39. Braithwaite D, Emery J, de Lusignan S, Sutton S. Using the internet to conduct surveys of health professionals: a valid alternative? Fam. Pract. 20(5), 545-551 (2003).
40. Dodson C, Van Riper M. Analysis of clinicians' attitudes towards pharmacogenomics. Per. Med. 8(5), 533-540 (2011).
41. Eccles MP, Hrisos S, Francis J et al. Do self-reported intentions predict clinicians' behaviour: a systematic review. Implement Sci. 1, 28 (2006).
42. Persky S, Kaphingst KA, Condit CM, McBride CM. Assessing hypothetical scenario methodology in genetic susceptibility testing analog studies: a quantitative review. Genet. Med. 9(11), 727-738 (2007).
43. Pyeritz RE. The family history: the first genetic test, and still useful after all those years? Genet. Med. 14(1), 3-9 (2012).
44. Offit K. Personalized medicine: new genomics, old lessons. Hum. Genet. 130, 3-14 (2011).
45. Green ED, Guyer MS. Charting a course for genomic medicine from base pairs to bedside. Nature 470, 204-213 (2011).